The 2026 WHO dementia guideline says hearing aids may be offered to adults with hearing loss as part of lowering dementia risk. For adults over 65, that means treating diagnosed hearing loss with tested hearing care, not buying a hearing aid as proven dementia prevention. A conditional recommendation means benefits likely outweigh harms for most people with the condition. The World Health Organization rates this hearing-aid advice as conditional with low-certainty evidence in its executive summary.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Read the official guidance from Who — Use this primary source to verify the official guidance.
- Read the official guidance from Who — Use this primary source to verify the official guidance.
Table of Contents
- What changed in 2026?
- What does low certainty mean?
- What did the ACHIEVE trial find?
- How to act after 65?
What changed in 2026?
The World Health Organization released the second edition of its cognitive-decline and dementia risk-reduction guidelines on 15 July 2026. The edition updates the 2019 first edition to reflect expanded evidence. For the first time, the World Health Organization states in its news release that hearing aids may be offered to adults with hearing loss as part of dementia-risk reduction.
The shift adds risk reduction alongside hearing function as a reason to offer tested hearing care. The World Health Organization estimates up to 45% of dementia risk could be prevented or delayed by addressing modifiable risks across life. No single intervention alone carries that total.
What does low certainty mean?
Low certainty does not mean no effect. It means benefits likely outweigh harms, but true effects may differ substantially. Health Detectors, summarizing the 2024 Lancet Commission work by Livingston and colleagues, notes eliminating hearing loss at population level would in theory avert about 7% of dementia cases.
That share assumes causality and corrects for overlap among risks. A population share is not a personal promise. It describes cases across a population, not protection for one aid user.
What did the ACHIEVE trial find?
The key randomized test is ACHIEVE, described in the Neuro.Wiki trial record. It assigned 977 U.S. adults aged 70–84 with untreated hearing loss to hearing aids plus counseling or to health education.
It found no overall 3-year cognitive difference. Benefit appeared only in the prespecified higher-risk ARIC subgroup of 238 participants, according to the Health Detectors summary. In that subgroup, hearing intervention slowed 3-year decline by about 48%. Treat that result as hypothesis-generating, not proof for all older adults.
How to act after 65?
For adults over 65, the World Health Organization executive summary points to tested hearing care for diagnosed loss plus attention to other risks. It does not present the conditional offer as proven dementia prevention.
Use the audiogram to guide settings, repairs, and rechecks. Keep using other risk care your clinician already advised.
- Ask for a formal hearing test when conversation gets harder.
- Choose fitted aids with counseling and scheduled follow-up.
- Bring results into a broader dementia-risk plan with your clinician.
You Might Also Like
- Air Pollution in the 2026 WHO Dementia Guideline: How Adults Over 65 Can Avoid Overreading the Headline
- Cross-Cultural Dementia Risk Programs After LatAm-FINGERS 2026: How Adults Over 65 Can Avoid Overreading the Headline
- PrecivityAD2 Testing for Symptomatic Adults 40 and Older in 2026: How People With Mild Cognitive Impairment Can Avoid Overreading the Headline
